ClinTec 'on track' with growth strategy as new offices open in Spain

By Melissa Fassbender contact

- Last updated on GMT

The offices will focus on clinical operations, project management, and regulatory functions. (Image: iStock/Rafal Olkis)
The offices will focus on clinical operations, project management, and regulatory functions. (Image: iStock/Rafal Olkis)

Related tags: European union, Contract research organization

ClinTec International has opened two new offices in Spain as it prepares for an expanding local clinical trial portfolio and larger outsourcing engagements in the country.

The Contract Research Organization (CRO) announced that it is moving to a larger office in Barcelona and opening a new office in Madrid earlier this week.

ClinTec International is adding significant depth in the main markets in the European Union, primarily driven by large scale oncology development programs​,” Bobby Bal, Executive Vice President, ClinTec International Limited, told Outsourcing-Pharma.com.

Bal explained that the company has recently observed “a significant growth in demand with key clients who require clinical trial execution in Spain​.” He added that the company is hiring a significant number of Clinical Research Associates (CRA) and Clinical Trial Assistants (CTA) within Spain. 

Our offices facilitate local clinical trial execution in Spain and Portugal, but also offer a gateway for Spanish clients to the rest of the ClinTec global infrastructure and functional services​,” explained Bal.

The offices will focus on clinical operations, project management, and regulatory functions.

As Outsourcing-Pharma.com previously reported​, the CRO began 2016 with two senior execute hires as part of the company’s growth strategy. In February, the company said it planned to grow considerably over the next 18 months.

ClinTec’s CEO and founder, Dr. Rabinder Buttar, described the expansion in Spain as a “new phase of development​,” adding that the company is now “on track to scale the organization considerably in the next 12 months as we enter our 20th year of growth​.”

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars